SeeFundsee funds clearly 🔍
Saved Sign in

PJP — Invesco Pharmaceuticals ETF

Data as of 2026-09-21 · US · Sectors · window 2016-09-21 → 2026-09-21 (10.0 years) · returns assume dividends reinvested, net of fund fees · Market Data from Tiingo.com

What the history says

PJP
Total return+117.0%
Annualised (CAGR)+8.1%
Volatility (annualised)+15.7%
Sharpe (rf = 0)0.51
Deepest drawdown-33.9%
Drawdown peak → trough2018-08-29 → 2020-03-23

Over the 10.0 years to 2026-09-21 the fund returned +117.0% in total (+8.1% a year), with a deepest drawdown of -33.9% from 2018-08-29 to 2020-03-23. Its worst calendar year was 2016 (-12.3%), its best 2025 (+28.0%).

Every calendar year

Calendar-year returns (net of fees, dividends reinvested)
YearPJP
2026+21.9%
2025+28.0%
2024+9.6%
2023-2.2%
2022-2.2%
2021+14.6%
2020+11.3%
2019+4.6%
2018-1.8%
2017+15.3%
2016-12.3%

What this page does not say

It does not say PJP is a good or bad fund, and it is not a forecast. Returns above are history: they already include dividends and already exclude the fund's own fees. A drawdown of -33.9% means an investor who bought at the peak would have watched that much value disappear before it recovered — how long that takes is the part most tables leave out.

Run your own window, add fees or a second fund: open PJP in the tool. History is shown as history, never sold as a forecast.

More in US · Sectors: COPX · AIRR · AMLP · all fund pages